Found: 7
Select item for more details and to access through your institution.
Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent Genes.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 8, p. 1080, doi. 10.3390/ph17081080
- By:
- Publication type:
- Article
Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory Upregulation of Other HER Family Members: Basis for Acquired Resistance and for Combination Therapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 272, doi. 10.3390/cells10020272
- By:
- Publication type:
- Article
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022).
- Published in:
- ChemMedChem, 2022, v. 17, n. 9, p. 1, doi. 10.1002/cmdc.202200210
- By:
- Publication type:
- Article
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors.
- Published in:
- ChemMedChem, 2022, v. 17, n. 9, p. 1, doi. 10.1002/cmdc.202100755
- By:
- Publication type:
- Article
SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 82, doi. 10.3390/ijms22010082
- By:
- Publication type:
- Article
Successful data applications: a cross-industry approach for conceptual planning.
- Published in:
- Journal of Business Chemistry, 2018, v. 15, n. 2, p. 71, doi. 10.17879/38129709602
- By:
- Publication type:
- Article
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 634, doi. 10.3390/cancers13040634
- By:
- Publication type:
- Article